PIPRA

PIPRA

Herstellung medizinischer Geräte

Reducing the Incidence of Delirium through Prevention

Info

PIPRA has developed a cutting-edge AI-based pre-surgical tool to assess patients’ risk of suffering from POD or POCD. A reliable pre-surgical risk assessment is urgently needed to improve preventive measures, consequent surgical outcomes and thus patients’ quality of life. POCD & POD More than 25% of patients aged over 60 suffer from cognitive impairment due to surgical complications. Disorientation, memory loss, difficulty in speech, and behavioral changes are among the symptoms experienced by patients affected by Post-Operative Delirium (POD) and Post-Operative Cognitive Decline/Dysfunction (POCD). These cognitive disorders result in a longer post-surgical recovery time, with increased hospital stays and associated costs. In addition, the most severe forms of perioperative cognitive disorders can lead to the admission in nursing homes due to significant functional and cognitive decline. Today, there is no effective POD and POCD treatment currently available. It is therefore crucial to prevent the onset of these disorders.

Website
http://pipra.ch
Branche
Herstellung medizinischer Geräte
Größe
2–10 Beschäftigte
Hauptsitz
Zurich
Art
Privatunternehmen
Gegründet
2019
Spezialgebiete
prevention, delirium, POD und postoperative delirium

Orte

Beschäftigte von PIPRA

Updates

Ähnliche Seiten

Finanzierung

PIPRA Insgesamt 3 Finanzierungsrunden

Letzte Runde

Seed

250.000,00 $

Weitere Informationen auf Crunchbase